Biological E seeks EUA for COVID vaccine Corbevax for children in 5-12 age group: Report

- Recently, the Subject Expert Committee recommended Emergency Use Authorization (EUA) for Biological E's COVID-19 vaccine Corbevax for the age group of 12 to 18 years under certain conditions.